José Manuel
Aramendía Beitia
Consultor Médico
Azucena
Aldaz Pastor
Consultora Farmacéutica
Publicaciones en las que colabora con Azucena Aldaz Pastor (2)
2023
-
A pharmacometrics model to define docetaxel target in early breast cancer
British Journal of Clinical Pharmacology, Vol. 89, Núm. 2, pp. 727-736
2007
-
Phase I and Pharmacokinetic Study of Gemcitabine Administered at Fixed-Dose Rate, Combined with Docetaxel/Melphalan/Carboplatin, with Autologous Hematopoietic Progenitor-Cell Support, in Patients with Advanced Refractory Tumors
Biology of Blood and Marrow Transplantation, Vol. 13, Núm. 11, pp. 1324-1337